MicroRNA and Markers and Therapeutic Response to Romosozumab and Abaloparatide in Postmenopausal Osteoporosis

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
MicroRNA and Markers and Therapeutic Response to Romosozumab and Abaloparatide in Postmenopausal Osteoporosis	Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, bone disorder, metabolic disease, musculoskeletal system disorder, osteoporosis	Recruiting	Not applicable	2026-06-01		NCT07616401

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Istituto Auxologico Italiano	75

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
IRCCS Ospedale Galeazzi Sant'Ambrogio	Milan	Italy	1
Istituto Auxologico Italiano IRCCS	Miano	Italy	1

Clinical trials